PDCD1 and melanoma: identified significant microbiome differences between melanoma patients responding and not responding to anti‐PD‐1 therapy, reporting that fecal microbiota transplantation (FMT) from responders enhances immune responses in germ‐free mice.[278] Additionally, Cao et al.